Get the Stockscreener App
189.45
1.98%
-3.83
After Hours:
189.45
Overview
News
Price History
Option Chain
Financials
Why ZTS Down?
Discussions
Forecast
Dividend History
Zoetis Inc stock is traded at $189.45, with a volume of 909.84K.
It is down -1.98% in the last 24 hours and down -1.66% over the past month.
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its us business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
See More
Previous Close:
$193.28
Open:
$192.48
24h Volume:
909.84K
Relative Volume:
0.54
Market Cap:
$85.97B
Revenue:
$8.92B
Net Income/Loss:
$2.34B
P/E Ratio:
38.51
EPS:
4.92
Net Cash Flow:
$2.10B
1W Performance:
-1.66%
1M Performance:
-1.66%
6M Performance:
+29.32%
1Y Performance:
+13.38%
1-Day Range:
$189.18
$193.00
1-Week Range:
$189.18
$196.55
52-Week Range:
$144.80
$201.92
Zoetis Inc Stock (ZTS) Company Profile
Zoetis Inc Stock (ZTS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-12-24 | Reiterated | Stifel | Buy |
| Dec-19-23 | Resumed | Jefferies | Buy |
| Dec-07-23 | Initiated | Exane BNP Paribas | Outperform |
| Sep-06-23 | Initiated | HSBC Securities | Buy |
| Jul-12-22 | Initiated | Piper Sandler | Overweight |
| Nov-18-21 | Initiated | Morgan Stanley | Overweight |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-16-21 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Mar-08-21 | Upgrade | BofA Securities | Neutral → Buy |
| Mar-08-21 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Sep-21-20 | Initiated | Atlantic Equities | Overweight |
| Aug-14-20 | Upgrade | Edward Jones | Hold → Buy |
| Aug-12-20 | Downgrade | Gabelli & Co | Buy → Hold |
| May-27-20 | Initiated | Jefferies | Buy |
| Jan-10-20 | Initiated | Raymond James | Mkt Perform |
| Sep-09-19 | Initiated | Goldman | Buy |
| Jul-01-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Jun-11-19 | Initiated | Barclays | Overweight |
| May-23-19 | Initiated | Guggenheim | Buy |
| May-03-19 | Downgrade | Gabelli & Co | Buy → Hold |
| Mar-20-19 | Initiated | SunTrust | Hold |
| Mar-04-19 | Upgrade | Stifel | Hold → Buy |
| Jan-23-19 | Initiated | UBS | Neutral |
| Oct-15-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Aug-22-18 | Downgrade | Stifel | Buy → Hold |
| Aug-03-18 | Reiterated | Stifel | Buy |
| Apr-19-18 | Reiterated | Citigroup | Buy |
| Mar-19-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Feb-16-18 | Reiterated | Stifel | Buy |
| Jan-04-18 | Upgrade | Citigroup | Neutral → Buy |
View All
Zoetis Inc Stock (ZTS) Latest News
Community Financial Services Group LLC Purchases 8,387 Shares of Zoetis Inc. (NYSE:ZTS) - MarketBeat
Flea and Tick Product Market to See Amazing Development | Zoetis, Elanco, Merck Animal Health - openPR
If EPS Growth Is Important To You, Zoetis (NYSE:ZTS) Presents An Opportunity - Yahoo Finance
Bleakley Financial Group LLC Decreases Stake in Zoetis Inc. (NYSE:ZTS) - MarketBeat
Zoetis's Q3 2024 Earnings: What to Expect - MSN
Dixon Mitchell Investment Counsel Inc. Has $16.95 Million Holdings in Zoetis Inc. (NYSE:ZTS) - MarketBeat
Zoetis' Q3 2024 Earnings: What to Expect - Nasdaq
Zoetis's Q3 2024 Earnings: What To Expect - Barchart
Zoetis Inc. (NYSE:ZTS) Holdings Raised by Vista Investment Partners LLC - MarketBeat
Bovine Mastitis Market Is Booming Worldwide 2024-2031 | Zoetis, - openPR
Veterinary Diagnostics Market Size, Growth, Opportunities - openPR
December 20th Options Now Available For Zoetis (ZTS) - Nasdaq
Why Is Zoetis (ZTS) Up 1.4% Since Last Earnings Report? - MSN
Zoetis Inc. (NYSE:ZTS) Shares Sold by AAFMAA Wealth Management & Trust LLC - MarketBeat
Roberts Wealth Advisors LLC Has $3.50 Million Stock Holdings in Zoetis Inc. (NYSE:ZTS) - MarketBeat
Animal Antibiotics and Antimicrobials Market (2024-2034):Zoetis, Inc., Merck & Co., Inc., Eli Lilly and Company, Bayer A - IndiaPolitics.com
Antiparasitic Drugs for Pets Market Research Report 2024 -Zoetis, Boehringer Ingelheim, Merck, Elanco, Virbac, Ceva, Vet – IndiaPolitics.com - IndiaPolitics.com
Pet Drug Market 2024 Segments Analysis by Top Key Players:Zoetis, Boehringer Ingelheim, Merck Animal Health, Elanco Anim – IndiaPolitics.com - IndiaPolitics.com
Pet DNA Testing Market Report 2024: Industry Analysis and - GlobeNewswire
Pet DNA Testing Market Report 2024: Industry Analysis and Forecast (2018-2030) with Share & Strategy Insights of Leading PlayersZoetis (Basepaws), Mars Petcare (Wisdom Panel), Orivet Genetic Pet Care & More - Yahoo Finance
Zoetis Inc. (NYSE:ZTS) Shares Bought by Sapient Capital LLC - MarketBeat
Pet Drug and Vaccine Market Growth Report |Zoetis, Boehringer Ingelheim, Merck Animal Health, Elanco Animal Health, Virb – IndiaPolitics.com - IndiaPolitics.com
Companion Animal Diagnosis Market Development Status 2034 |IDEXX Laboratories, Zoetis, Heska Corporation, Thermo Fisher – IndiaPolitics.com - IndiaPolitics.com
Zoetis Inc. (NYSE:ZTS) Shares Acquired by Thomasville National Bank - MarketBeat
Farm Animals Medicines and Vaccines Industry to Witness an Outstanding Growth by 2030 |Zoetis, Boehringer Ingelheim, Mer – IndiaPolitics.com - IndiaPolitics.com
Veterinary Biomarker Test Product Market Is Going to Boom |Zoetis, Virbac, Life Diagnostics, ACUVET BIOTECH, Merck & Co. – IndiaPolitics.com - IndiaPolitics.com
Pets Antibiotic Treatment Solutions Market Growing Massively by-Merck, Elanco, Zoetis, Virbac, Dechra Veterinary Product – IndiaPolitics.com - IndiaPolitics.com
Gene Deletion Vaccine Market Statistical Forecast, Trade Analysis 2024 –Virbac SA, Merck Animal Health, Zoetis Inc, Boeh – IndiaPolitics.com - IndiaPolitics.com
Meyer Handelman Co. Sells 2,800 Shares of Zoetis Inc. (NYSE:ZTS) - MarketBeat
Covea Finance Buys 49,000 Shares of Zoetis Inc. (NYSE:ZTS) - MarketBeat
Zoetis Inc. Announces Quarterly Dividend of $0.43 (NYSE:ZTS) - MarketBeat
In-Depth Examination Of 7 Analyst Recommendations For Zoetis - Benzinga
Zoetis (NYSE:ZTS) Price Target Raised to $230.00 - MarketBeat
Zoetis Inc. (NYSE:ZTS) is Sarasin & Partners LLP's 7th Largest Position - MarketBeat
United States Veterinary Oncology Market, Forecast & - GlobeNewswire
United States Veterinary Oncology Market, Forecast & Opportunities Report to 2029, Featuring Zoetis, Virbac, Ardent Animal Health, Varian Medical Systems, PetVet Care Centers and More - Yahoo Finance
Zoetis sets Q4 dividend at $0.432 per share - Investing.com India
Zoetis Inc. (ZTS) Declares Fourth Quarter Dividend - GuruFocus.com
Animal Medication Co. Sued Over Dog Arthritis Treatment Risks - Law360
Zoetis Announces Q4 Dividend; Cautions on Future Uncertainties - TipRanks
Zoetis sets Q4 dividend at $0.432 per share By Investing.com - Investing.com Canada
Zoetis Declares Fourth Quarter 2024 Dividend - Business Wire
Steigerwald Gordon & Koch Inc. Grows Position in Zoetis Inc. (NYSE:ZTS) - MarketBeat
OCI 2024: Zoetis gives America’s best friend a voice through its toys - PharmaLive
Local veterinarians give to chapter - The Daily Advocate
Zoetis to Premiere New Born of the Bond Series Season at World Dairy Expo - Hoard's Dairyman
Zoetis: A solid choice for the young dividend growth investor (NYSE:ZTS) - Seeking Alpha
Zoetis Inc. (NYSE:ZTS) Shares Purchased by Artemis Investment Management LLP - MarketBeat
Zoetis Inc. (NYSE:ZTS) Shares Acquired by Alpha Cubed Investments LLC - Defense World
Livestock Monitoring Market to Witness Stunning Growth |DeLaval, Allflex Livestock Intelligence, Zoetis - IndiaPolitics.com
Animal Pain Medicines Market Global Growth Report To 2031 | Zoetis Inc, Elanco Animal Health Incorporated, Merck & Co., Inc, Dechra Pharmaceuticals, Vetoquinol, SeQuent Scientific Limited – Times-BD24 - Times-BD24
Zoetis Inc Stock (ZTS) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.09%
1.28%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):